Search
for
Sort by
Research 511–540 of 1000+
- Viva questions from the IJDVL
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Platelet-rich plasma: The journey so far !
- Harnessing Regenerative Science in Aesthetic Surgery: The Biologically Driven Future
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Aplicações clínicas em humanos do plasma rico em plaquetas: revisão integrativa
- Ten years of injectable platelet‐rich fibrin
- A randomized, controlled pilot trial comparing platelet-rich plasma to topical minoxidil foam for treatment of androgenic alopecia in women
- Comparative study between fractional carbon dioxide laser versus intralesional steroids injection in treatment of alopecia areata
- Dermatologic manifestations of endocrine disorders
- Management of Hair Loss
- Alopecia Areata
- Dermatosis associated with menopause
- Treatment of scleromyxoedema with hydroxychloroquine
- Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers
- Fibrosing Frontal Alopecia: A comprehensive study to understand its etiology
- A CLINICAL STUDY OF PATTERN OF SKIN MANIFESTATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ATTENDING DERMATOLOGY OPD IN A TERTIARY CARE CENTRE
- Hair Loss in Women
- Dermatologic therapy: December 1986 to December 1987
- Drug-Induced Skin, Nail and Hair Disorders
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- Hair loss
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Metabolism and skin diseases
- Platelet-rich fibrin in the management of oral mucosal lesions: a scoping review
- Coexistence of angiolymphoid hyperplasia with eosinophilia and pulmonary neoplasia
- Managing Menopausal Skin: A Clinician’s Review
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Hair Disorders
- Dermatological drugs, topical agents, and cosmetics